Mechanisms of carbon nanotube-induced toxicity: Focus on pulmonary inflammation

Advanced Drug Delivery Reviews

Volumn 65, Issue 15, 2013, Pages 2087-2097

  Bhattacharya, Kunal ^a   Andón, Fernando Torres ^a   El Sayed, Ramy ^a   Fadeel, Bengt ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Bio corona; Biodegradation; Carbon nanotubes; Eosinophils; Inflammasome; Macrophages; Mast cells; Neutrophils

Indexed keywords

BIO-CORONA; EOSINOPHILS; INFLAMMASOME; MAST CELLS; NEUTROPHILS;

BIODEGRADATION; CYTOLOGY; ELECTRONIC PROPERTIES; MACROPHAGES; PATHOLOGY; PHYSIOLOGY; TISSUE HOMEOSTASIS; TOXICITY;

CARBON NANOTUBES;

CARBON NANOTUBE; CYTOKINE; INFLAMMASOME;

BIODEGRADATION; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CYTOKINE RELEASE; ENZYME DEGRADATION; EOSINOPHIL; FIBROSIS; HUMAN; INFLAMMATION; MACROPHAGE; MAST CELL; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; REVIEW;

BIO-CORONA; BIODEGRADATION; CARBON NANOTUBES; EOSINOPHILS; INFLAMMASOME; MACROPHAGES; MAST CELLS; NEUTROPHILS;

ANIMALS; CHRONIC DISEASE; CYTOKINES; EOSINOPHILS; HUMANS; INFLAMMATION MEDIATORS; MACROPHAGES; NANOTUBES, CARBON; NEUTROPHILS; PNEUMONIA;

EID: 84889260511     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2013.05.012     Document Type: Review

References (115)

1. Fadeel B., Feliu N., Vogt C., Abdelmonem A.M., Parak W.J. Bridge over troubled waters: understanding the synthetic and biological identities of engineered nanomaterials. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2013, 5:111-129.
2. Shvedova A.A., Pietroiusti A., Fadeel B., Kagan V.E. Mechanisms of carbon nanotube-induced toxicity: focus on oxidative stress. Toxicol. Appl. Pharmacol. 2012, 261:121-133.
3. Monopoli M.P., Aberg C., Salvati A., Dawson K.A. Biomolecular coronas provide the biological identity of nanosized materials. Nat. Nanotechnol. 2012, 7:779-786.
4. Castranova V., Schulte P.A., Zumwalde R.D. Occupational nanosafety considerations for carbon nanotubes and carbon nanofibers. Acc. Chem. Res. 2013, 46:642-649.
5. Nathan C. Points of control in inflammation. Nature 2002, 420:846-852.
6. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435.
7. Underhill D.M., Goodridge H.S. Information processing during phagocytosis. Nat. Rev. Immunol. 2012, 12:492-502.
8. Galli S.J., Borregaard N., Wynn T.A. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat. Immunol. 2011, 12:1035-1044.
9. Geissmann F., Gordon S., Hume D.A., Mowat A.M., Randolph G.J. Unravelling mononuclear phagocyte heterogeneity. Nat. Rev. Immunol. 2010, 10:453-460.
10. Hume D.A. Macrophages as APC and the dendritic cell myth. J. Immunol. 2008, 181:5829-5835.
11. Lamkanfi M., Dixit V.M. Inflammasomes and their roles in health and disease. Annu. Rev. Cell Dev. Biol. 2012, 28:137-161.
12. Brinkmann V., Zychlinsky A. Beneficial suicide: why neutrophils die to make NETs. Nat. Rev. Microbiol. 2007, 5:577-582.
13. Fulkerson P.C., Rothenberg M.E. Targeting eosinophils in allergy, inflammation and beyond. Nat. Rev. Drug Discov. 2013, 12:117-129.
14. Holgate S.T. Innate and adaptive immune responses in asthma. Nat. Med. 2012, 18:673-683.
15. Enoksson M., Lyberg K., Möller-Westerberg C., Fallon P.G., Nilsson G., Lunderius-Andersson C. Mast cells as sensors of cell injury through IL-33 recognition. J. Immunol. 2011, 186:2523-2528.
16. Fernandez E.J., Lolis E. Structure, function, and inhibtion of chemokines. Annu. Rev. Pharmacol. Toxicol. 2002, 42:469-499.
17. Dinarello C.A., Simon A., van der Meer J.W.M. Treating inflammation by blocking Interleukin-1 in a broad spectrum of diseases. Nat. Rev. Drug Discov. 2012, 11:633-652.
18. Ricklin D., Hajishengallis G., Yang K., Lambris J.D. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11:785-797.
19. Strowig T., Henao-Mejia J., Elinav E., Flavell R. Inflammasomes in health and disease. Nature 2012, 481:278-286.
20. von Moltke J., Trinidad N.J., Moayeri M., Kintzer A.F., Wang S.B., van Rooijen N., Brown C.R., Krantz B.A., Leppla S.H., Gronert K., Vance R.E. Rapid induction of inflammatory lipid mediators by the inflammasome in vivo. Nature 2012, 490:107-111.
21. Dagenais M., Skeldon A., Saleh M. The inflammasome: in memory of Dr. Jurg Tschopp. Cell Death Differ. 2012, 19:5-12.
22. Dostert C., Pétrilli V., Van Bruggen R., Steele C., Mossman B.T., Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320:674-677.
23. Anand P.K., Malireddi R.K.S., Lukens J.R., Vogel P., Bertin J., Lamkanfi M., Kanneganti T.-D. NLRP6 negatively regulates innate immunity and host defence against bacterial pathogens. Nature 2012, 488:389-393.
24. Bianchi M.E. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 2007, 81:1-5.
25. Juliana C., Fernandes-Alnemri T., Kang S., Farias A., Qin F., Alnemri E.S. Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation. J. Biol. Chem. 2012, 287:36617-36622.
26. Mayer-Barber K.D., Barber D.L., Shenderov K., White S.D., Wilson M.S., Cheever A., Kugler D., Hieny S., Caspar P., Núñez G., Schlueter D., Flavell R.A., Sutterwala F.S., Sher A. Cutting edge: caspase-1 independent IL-1β production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. J. Immunol. 2010, 184:3326-3330.
27. Zhou R., Yazdi A.S., Menu P., Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469:221-225.
28. Shimada K., Crother T.R., Karlin J., Dagvadorj J., Chiba N., Chen S., Ramanujan V.K., Wolf A.J., Vergnes L., Ojcius D.M., Rentsendorj A., Vargas M., Guerrero C., Wang Y., Fitzgerald K.A., Underhill D.M., Town T., Arditi M. Oxidized mitochondrial D activates the NLRP3 inflammasome during apoptosis. Immunity 2012, 36:401-414.
29. Riteau N., Baron L., Villeret B., Guillou N., Savigny F., Ryffel B., Rassendren F., Le Bert M., Gombault A., Couillin I. ATP release and purinergic signaling: a common pathway for particle-mediated inflammasome activation. Cell Death Dis. 2012, 3:e403.
30. Rossol M., Pierer M., Raulien N., Quandt D., Meusch U., Rothe K., Schubert K., Schöneberg T., Schaefer M., Krügel U., Smajilovic S., Bräuner-Osborne H., Baerwald C., Wagner U. Extracellular Ca2+ is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors. Nat. Commun. 2012, 3:1329.
31. Malik A.F., Hoque R., Ouyang X., Ghani A., Hong E., Khan K., Moore L.B., Ng G., Munro F., Flavell R.A., Shi Y., Kyriakides T.R., Mehal W.Z. Inflammasome components Asc and caspase-1 mediate biomaterial-induced inflammation and foreign body response. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:20095-20100.
32. Morimoto Y., Horie M., Kobayashi N., Shinohara N., Shimada M. Inhalation toxicity assessment of carbon-based nanoparticles. Acc. Chem. Res. 2013, 46:770-781.
33. Shvedova A.A., Kisin E.R., Mercer R., Murray A.R., Johnson V.J., Potapovich A.I., Tyurina Y.Y., Gorelik O., Arepalli S., Schwegler-Berry D., Hubbs A.F., Antonini J., Evans D.E., Ku B.-K., Ramsey D., Maynard A., Kagan V.E., Castranova V., Baron P. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289:L698-L708.
34. Shvedova A.A., Kisin E., Murray A.R., Johnson V.J., Gorelik O., Arepalli S., Hubbs A.F., Mercer R.R., Keohavong P., Sussman N., Jin J., Yin J., Stone S., Chen B.T., Deye G., Maynard A., Castranova V., Baron P.A., Kagan V.E. Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 295:L552-L565.
35. Shvedova A.A., Kisin E.R., Murray A.R., Kommineni C., Castranova V., Fadeel B., Kagan V.E. Increased accumulation of neutrophils and decreased fibrosis in the lung of NADPH oxidase-deficient C57BL/6 mice exposed to carbon nanotubes. Toxicol. Appl. Pharmacol. 2008, 231:235-240.
36. Huizar I., Malur A., Patel J., McPeek M., Dobbs L., Wingard C., Barna B., Thomassen M.J. The role of PPARγ in carbon nanotube-elicited granulomatous lung inflammation. Respir. Res. 2013, 14:7.
37. Mercer R.R., Scabilloni J., Wang L., Kisin E., Murray A.R., Schwegler-Berry D., Shvedova A.A., Castranova V. Alteration of deposition pattern and pulmonary response as a result of improved dispersion of aspirated single-walled carbon nanotubes in a mouse model. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 294:L87-L97.
38. Mutlu G.K.M., Budinger G.R.S., Green A.A., Urich D., Soberanes S., Chiarella S.E., Alheid G.F., McCrimmon D.R., Szleifer I., Hersam M.C. Biocompatible nanoscale dispersion of single-walled carbon nanotubes minimizes in vivo pulmonary toxicity. Nano Lett. 2010, 10:1664-1670.
39. Murray A., Kisin E., Tkach A., Yanamala N., Mercer R., Young S.H., Fadeel B., Kagan V., Shvedova A. Factoring-in agglomeration of carbon nanotubes and nanofibers for better prediction of their toxicity versus asbestos. Part. Fibre Toxicol. 2012, 9:10.
40. Wang X., Xia T., Addo Ntim S., Ji Z., Lin S., Meng H., Chung C.H., George S., Zhang H., Wang M., Li N., Yang Y., Castranova V., Mitra S., Bonner J.C., Nel A.E. Dispersal state of multiwalled carbon nanotubes elicits profibrogenic cellular responses that correlate with fibrogenesis biomarkers and fibrosis in the murine lung. ACS Nano 2011, 5:9772-9787.
41. Tabet L., Bussy C., Setyan A., Simon-Deckers A., Rossi M., Boczkowski J., Lanone S. Coating carbon nanotubes with a polystyrene-based polymer protects against pulmonary toxicity. Part. Fibre Toxicol. 2011, 8:3.
42. Poland C.A., Duffin R., Kinloch I., Maynard A., Wallace W.A.H., Seaton A., Stone V., Brown S., MacNee W., Donaldson K. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat. Nanotechnol. 2008, 3:423-428.
43. Murphy F.A., Poland C.A., Duffin R., Al-Jamal K.T., Ali-Boucetta H., Nunes A., Byrne F., Prina-Mello A., Volkov Y., Li S., Mather S.J., Bianco A., Prato M., MacNee W., Wallace W.A., Kostarelos K., Donaldson K. Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura. Am. J. Pathol. 2011, 178:2587-2600.
44. Ryman-Rasmussen J.P., Cesta M.F., Brody A.R., Shipley-Phillips J.K., Everitt J.I., Tewksbury E.W., Moss O.R., Wong B.A., Dodd D.E., Andersen M.E., Bonner J.C. Inhaled carbon nanotubes reach the subpleural tissue in mice. Nat. Nanotechnol. 2009, 4:747-751.
45. Nagai H., Okazaki Y., Chew S.H., Misawa N., Yamashita Y., Akatsuka S., Ishihara T., Yamashita K., Yoshikawa Y., Yasui H., Jiang L., Ohara H., Takahashi T., Ichihara G., Kostarelos K., Miyata Y., Shinohara H., Toyokuni S. Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:E1330-E1338.
46. Muller J., Huaux F., Fonseca A., Nagy J.B., Moreau N., Delos M., Raymundo-Piñero F., Béguin E., Kirsch-Volders M., Fenoglio I., Fubini B., Lison D. Structural defects play a major role in the acute lung toxicity of multiwall carbon nanotubes: toxicological aspects. Chem. Res. Toxicol. 2008, 21:1698-1705.
47. Bussy C., Pinault M., Cambedouzou J., Landry M., Jegou P., Mayne-L'hermite M., Launois P., Boczkowski J., Lanone S. Critical role of surface chemical modifications induced by length shortening on multi-walled carbon nanotubes-induced toxicity. Part. Fibre Toxicol. 2012, 9:46.
48. Ali-Boucetta H., Nunes A., Sainz R., Herrero M.A., Tian B., Prato M., Bianco A., Kostarelos K. Asbestos-like pathogenicity of long carbon nanotubes alleviated by chemical functionalization. Angew. Chem. Int. Ed. 2013, 52:2274-2278.
49. Murphy F., Schinwald A., Poland C., Donaldson K. The mechanism of pleural inflammation by long carbon nanotubes: interaction of long fibres with macrophages stimulates them to amplify pro-inflammatory responses in mesothelial cells. Part. Fibre Toxicol. 2012, 9:8.
50. He X., Young S.H., Schwegler-Berry D., Chisholm W.P., Fernback J.E., Ma Q. Multiwalled carbon nanotubes induce a fibrogenic response by stimulating reactive oxygen species production, activating NF-κB signaling, and promoting fibroblast-to-myofibroblast transformation. Chem. Res. Toxicol. 2011, 24:2237-2248.
51. Inoue K., Koike E., Yanagisawa R., Hirano S., Nishikawa M., Takano H. Effects of multi-walled carbon nanotubes on a murine allergic airway inflammation model. Toxicol. Appl. Pharmacol. 2009, 237:306-316.
52. Nygaard U.C., Hansen J.S., Samuelsen M., Alberg T., Marioara C.D., Løvik M. Single-walled and multi-walled carbon nanotubes promote allergic immune responses in mice. J. Toxicol. Sci. 2009, 109:113-123.
53. Inoue K., Yanagisawa R., Koike E., Nishikawa M., Takano H. Repeated pulmonary exposure to single-walled carbon nanotubes exacerbates allergic inflammation of the airway: possible role of oxidative stress. Free Radic. Biol. Med. 2010, 48:924-934.
54. Erdely A., Liston A., Salmen-Muniz R., Hulderman T., Young S.H., Zeidler-Erdely P.C., Castranova V., Simeonova P.P. Identification of systemic markers from a pulmonary carbon nanotube exposure. J. Occup. Environ. Med. 2011, 53:S80-S86.
55. Laverny G., Casset A., Purohit A., Schaeffer E., Spiegelhalter C., de Blay F., Pons F. Immunomodulatory properties of multi-walled carbon nanotubes in peripheral blood mononuclear cells from healthy subjects and allergic patients. Toxicol. Lett. 2013, 217:91-101.
56. Yagami A., Orihara K., Morita H., Futamura K., Hashimoto N., Matsumoto K., Saito H., Matsuda A. IL-33 mediates inflammatory responses in human lung tissue cells. J. Immunol. 2010, 185:5743-5750.
57. Katwa P., Wang X., Urankar R.N., Podila R., Hilderbrand S.C., Fick R.B., Rao A.M., Ke P.C., Wingard C.J., Brown J.M. A carbon nanotube toxicity paradigm driven by mast cells and the IL-33/ST2 axis. Small 2012, 8:2904-2912.
58. Beamer C.A., Girtsman T.A., Seaver B.P., Finsaas K.J., Migliaccio C.T., Perry V.K., Rottman J.B., Smith D.E., Holian A. IL-33 mediates multi-walled carbon nanotube (MWCNT)-induced airway hyper-reactivity via the mobilization of innate helper cells in the lung. Nanotoxicology June 29 2012, (Epub ahead of print).
59. Spits H., Artis D., Colonna M., Diefenbach A., Di Santo J.P., Eberl G., Koyasu S., Locksley R.M., McKenzie A.N.J., Mebius R.E., Powrie F., Vivier E. Innate lymphoid cells - a proposal for uniform nomenclature. Nat. Rev. Immunol. 2013, 13:145-149.
60. Park E.J., Roh J., Kim S.N., Kim Y., Han S.B., Hong J.T. CCR5 plays an important role in resolving an inflammatory response to single-walled carbon nanotubes. J. Appl. Toxicol. Mar 22 2012, (Epub ahead of print).
61. Chou C.C., Hsiao H.Y., Hong Q.S., Chen C.H., Peng Y.W., Chen H.W., Yang P.C. Single-walled carbon nanotubes can induce pulmonary injury in mouse model. Nano Lett. 2008, 8:437-445.
62. Hsieh W.Y., Chou C.C., Ho C.C., Yu S.L., Chen H.Y., Chou H.Y.E., Chen J.J.W., Chen H.-W., Yang P.C. Single-walled carbon nanotubes induce airway hyperreactivity and parenchymal injury in mice. Am. J. Respir. Cell Mol. Biol. 2012, 46:257-267.
63. Tkach A.V., Shurin G.V., Shurin M.R., Kisin E.R., Murray A.R., Young S.H., Star A., Fadeel B., Kagan V.E., Shvedova A.A. Direct effects of carbon nanotubes on dendritic cells induce immune suppression upon pulmonary exposure. ACS Nano 2011, 5:5755-5762.
64. Koya T., Matsuda H., Matsubara S., Miyahara N., Dakhama A., Takeda K., Gelfand E.W. Differential effects of dendritic cell transfer on airway hyperresponsiveness and inflammation. Am. J. Respir. Cell Mol. Biol. 2009, 41:271-280.
65. Fadeel B. Clear and present danger? Engineered nanoparticles and the immune system. Swiss Med. Wkly. 2012, 142:w13609.
66. Monopoli M.P., Walczyk D., Campbell A., Elia G., Lynch I., Bombelli F.B., Dawson K.A. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 2011, 133:2525-2534.
67. Salvati A., Pitek A.S., Monopoli M.P., Prapainop K., Bombelli F.B., Hristov D.R., Kelly P.M., Aberg C., Mahon E., Dawson K.A. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat. Nanotechnol. 2013, 8:137-143.
68. Lundqvist M., Stigler J., Elia G., Lynch I., Cedervall T., Dawson K.A. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:14265-14270.
69. Tenzer S., Docter D., Rosfa S., Wlodarski A., Kuharev J., Rekik A., Knauer S.K., Bantz C., Nawroth T., Bier C., Sirirattanapan J., Mann W., Treuel L., Zellner R., Maskos M., Schild H., Stauber R.H. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano 2011, 5:7155-7167.
70. Casals E., Pfaller T., Duschl A., Oostingh G.J., Puntes V.F. Hardening of the nanoparticle-protein corona in metal (Au, Ag) and oxide (Fe3O4, CoO, and CeO2) nanoparticles. Small 2011, 7:3479-3486.
71. Cai X., Ramalingam R., Wong H.S., Cheng J., Ajuh P., Cheng S.H., Lam Y.W. Characterization of carbon nanotube protein corona by using quantitative proteomics. Nanomedicine 2012, S1549-9634:597.
72. Kapralov A.A., Feng W.H., Amoscato A.A., Yanamala N., Balasubramanian K., Winnica D.E., Kisin E.R., Kotchey G.P., Gou P., Sparvero L.J., Ray P., Mallampalli R.K., Klein-Seetharaman J., Fadeel B., Star A., Shvedova A.A., Kagan V.E. Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration. ACS Nano 2012, 6:4147-4156.
73. Ge C., Du J., Zhao L., Wang L., Liu Y., Li D., Yang Y., Zhou R., Zhao Y., Chai Z., Chen C. Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:16968-16973.
74. Dutta D., Sundaram S.K., Teeguarden J.G., Riley B.J., Fifield L.S., Jacobs J.M., Addleman S.R., Kaysen G.A., Moudgil B.M., Weber T.J. Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. Toxicol. Sci. 2007, 100:303-315.
75. Dong P.X., Wan B., Wang Z.X., Guo L.H., Yang Y., Zhao L. Exposure of single-walled carbon nanotubes impairs the functions of primarily cultured murine peritoneal macrophages. Nanotoxicology Jun 14 2012, (Epub ahead of print).
76. Guo F., Ma N., Horibe Y., Kawanishi S., Murata M., Hiraku Y. Nitrative DNA damage induced by multi-walled carbon nanotube via endocytosis in human lung epithelial cells. Toxicol. Appl. Pharmacol. 2012, 260:183-192.
77. Yaron P., Holt B., Short P., Losche M., Islam M., Dahl K. Single-wall carbon nanotubes enter cells by endocytosis and not membrane penetration. J. Nanobiotechnol. 2011, 9:45.
78. Konduru N.V., Tyurina Y.Y., Feng W., Basova L.V., Belikova N.A., Bayir H., Clark K., Rubin M., Stolz D., Vallhov H., Scheynius A., Witasp E., Fadeel B., Kichambare P.D., Star A., Kisin E.R., Murray A.R., Shvedova A.A., Kagan V.E. Phosphatidylserine targets single-walled carbon nanotubes to professional phagocytes in vitro and in vivo. PLoS One 2009, 4:e4398.
79. Gao N., Zhang Q., Mu Q., Bai Y., Li L., Zhou H., Butch E.R., Powell T.B., Snyder S.E., Jiang G., Yan B. Steering carbon nanotubes to scavenger receptor recognition by nanotube surface chemistry modification partially alleviates NF-κB activation and reduces its immunotoxicity. ACS Nano 2011, 5:4581-4591.
80. Andersen A.J., Wibroe P.P., Moghimi S.M. Perspectives on carbon nanotube-mediated adverse immune effects. Adv. Drug Deliv. Rev. 2012, 64:1700-1705.
81. Rybak-Smith M.J., Sim R.B. Complement activation by carbon nanotubes. Adv. Drug Deliv. Rev. 2011, 63:1031-1041.
82. Ling W.L., Biro A., Bally I., Tacnet P., Deniaud A., Doris E., Frachet P., Schoehn G., Pebay-Peyroula E., Arlaud G.J. Proteins of the innate immune system crystallize on carbon nanotubes but are not activated. ACS Nano 2011, 5:730-737.
83. Salvador-Morales C., Flahaut E., Sim E., Sloan J., Green M.L.H., Sim R.B. Complement activation and protein adsorption by carbon nanotubes. Mol. Immunol. 2006, 43:193-201.
84. Hamad I., Hunter A.C., Rutt K.J., Liu Z., Dai H., Moghimi S.M. Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover. Mol. Immunol. 2008, 45:3797-3803.
85. Hamad I., Al-Hanbali O., Hunter A.C., Rutt K.J., Andresen T.L., Moghimi S.M. Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineering. ACS Nano 2010, 4:6629-6638.
86. Andersen A.J., Robinson J.T., Dai H., Hunter A.C., Andresen T.L., Moghimi S.M. Single-walled carbon nanotube surface control of complement recognition and activation. ACS Nano 2013, 7:1108-1119.
87. Dekali S., Divetain A., Kortulewski T., Vanbaelinghem J., Gamez C., Rogerieux F., Lacroix G., Rat P. Cell cooperation and role of the P2X7 receptor in pulmonary inflammation induced by nanoparticles. Nanotoxicology Oct 24 2012, (Epub ahead of print).
88. Yazdi A.S., Guarda G., Riteau N., Drexler S.K., Tardivel A., Couillin I., Tschopp J. Nanoparticles activate the NLR pyrin domain containing 3 (NLRP3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:19449-19454.
89. Sandberg W., Lag M., Holme J., Friede B., Gualtieri M., Kruszewski M., Schwarze P., Skuland T., Refsnes M. Comparison of non-crystalline silica nanoparticles in IL-1β release from macrophages. Part. Fibre Toxicol. 2012, 9:32.
90. Yang E.J., Kim S., Kim J.S., Choi I.H. Inflammasome formation and IL-1β release by human blood monocytes in response to silver nanoparticles. Biomaterials 2012, 33:6858-6867.
91. Palomäki J., Välimäki E., Sund J., Vippola M., Clausen P.A., Jensen K.A., Savolainen K., Matikainen S., Alenius H. Long, needle-like carbon nanotubes and asbestos activate the NLRP3 inflammasome through a similar mechanism. ACS Nano 2011, 5:6861-6870.
92. Meunier E., Coste A., Olagnier D., Authier H., Lefèvre L., Dardenne C., Bernad J., Béraud M., Flahaut E., Pipy B. Double-walled carbon nanotubes trigger IL-1β release in human monocytes through NLRP3 inflammasome activation. Nanomedicine 2012, 8:987-995.
93. Lunov O., Syrovets T., Loos C., Nienhaus G.U., Mailänder V., Landfester K., Rouis M., Simmet T. Amino-functionalized polystyrene nanoparticles activate the NLRP3 inflammasome in human macrophages. ACS Nano 2011, 5:9648-9657.
94. 2 nanoparticles in murine dendritic cells. Nanotoxicology 2011, 5:326-340.
95. Wang X., Xia T., Duch M.C., Ji Z., Zhang H., Li R., Sun B., Lin S., Meng H., Liao Y.-P., Wang M., Song T.-B., Yang Y., Hersam M.C., Nel A.E. Pluronic F108 coating decreases the lung fibrosis potential of multiwall carbon nanotubes by reducing lysosomal injury. Nano Lett. 2012, 12:3050-3061.
96. Vallhov H., Qin J., Johansson S.M., Ahlborg N., Muhammed M.A., Scheynius A., Gabrielsson S. The importance of an endotoxin-free environment during the production of nanoparticles used in medical applications. Nano Lett. 2006, 6:1682-1686.
97. Delogu L.G., Stanford S.M., Santelli E., Magrini A., Bergamaschi A., Motamedchaboki K., Rosato N., Mustelin T., Bottini N., Bottini M. Carbon nanotube-based nanocarriers: the importance of keeping it clean. J. Nanosci. Nanotechnol. 2010, 10:5293-5301.
98. Andón F.T., Fadeel B. Programmed cell death: molecular mechanisms and implications for safety assessment of nanomaterials. Acc. Chem. Res. 2012, 46:733-742.
99. Reisetter A.C., Stebounova L.V., Baltrusaitis J., Powers L., Gupta A., Grassian V.H., Monick M.M. Induction of inflammasome-dependent pyroptosis by carbon black nanoparticles. J. Biol. Chem. 2011, 286:21844-21852.
100. Compan V., Baroja-Mazo A., López-Castejón G., Gomez A.I., Martínez C.M., Angosto D., Montero M.T., Herranz A.S., Bazán E., Reimers D., Mulero V., Pelegrín P. Cell volume regulation modulates NLRP3 inflammasome activation. Immunity 2012, 37:487-500.
101. Sun B., Wang X., Ji Z., Li R., Xia T. NLRP3 inflammasome activation induced by engineered nanomaterials. Small 2012, 9:1595-1607.
102. Allen B.L., Kichambare P.D., Gou P., Vlasova I.I., Kapralov A.A., Konduru N., Kagan V.E., Star A. Biodegradation of single-walled carbon nanotubes through enzymatic catalysis. Nano Lett. 2008, 8:3899-3903.
103. Allen B.L., Kotchey G.P., Chen Y., Yanamala N.V., Klein-Seetharaman J., Kagan V.E., Star A. Mechanistic investigations of horseradish peroxidase-catalyzed degradation of single-walled carbon nanotubes. J. Am. Chem. Soc. 2009, 131:17194-17205.
104. Liu X., Hurt R.H., Kane A.B. Biodurability of single-walled carbon nanotubes depends on surface functionalization. Carbon 2010, 48:1961-1969.
105. Kotchey G.P., Allen B.L., Vedala H., Yanamala N., Kapralov A.A., Tyurina Y.Y., Klein-Seetharaman J., Kagan V.E., Star A. The enzymatic oxidation of graphene oxide. ACS Nano 2011, 5:2098-2108.
106. Zhao Y., Allen B.L., Star A. Enzymatic degradation of multiwalled carbon nanotubes. J. Phys. Chem. A 2011, 115:9536-9544.
107. Russier J., Menard-Moyon C., Venturelli E., Gravel E., Marcolongo G., Meneghetti M., Doris E., Bianco A. Oxidative biodegradation of single- and multi-walled carbon nanotubes. Nanoscale 2011, 3:893-896.
108. Kagan V.E., Konduru N.V., Feng W., Allen B.L., Conroy J., Volkov Y., Vlasova I.I., Belikova N.A., Yanamala N., Kapralov A., Tyurina Y.Y., Shi J., Kisin E.R., Murray A.R., Franks J., Stolz D., Gou P., Klein-Seetharaman J., Fadeel B., Star A., Shvedova A.A. Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation. Nat. Nanotechnol. 2010, 5:354-359.
109. Arnhold J., Flemmig J. Human myeloperoxidase in innate and acquired immunity. Arch. Biochem. Biophys. 2010, 500:92-106.
110. Vlasova I.I., Vakhrusheva T.V., Sokolov A.V., Kostevich V.A., Gusev A.A., Gusev S.A., Melnikova V.I., Lobach A.S. PEGylated single-walled carbon nanotubes activate neutrophils to increase production of hypochlorous acid, the oxidant capable of degrading nanotubes. Toxicol. Appl. Pharmacol. 2012, 264:131-142.
111. Shvedova A.A., Kapralov A.A., Feng W.H., Kisin E.R., Murray A.R., Mercer R.R., Croix C.M.St., Lang M.A., Watkins S.C., Konduru N.V., Allen B.L., Conroy J., Kotchey G.P., Mohamed B.M., Meade A.D., Volkov Y., Star A., Fadeel B., Kagan V.E. Impaired clearance and enhanced pulmonary inflammatory/fibrotic response to carbon nanotubes in myeloperoxidase-deficient mice. PLoS One 2012, 7:e30923.
112. Andón F.T., Kapralov A.A., Yanamala N., Feng W., Baygan A., Chambers B.J., Hultenby K., Ye F., Toprak M.S., Brandner B.D., Fornara A., Klein-Seetharaman J., Kotchey G.P., Star A., Shvedova A.A., Fadeel B., Kagan V.E. Biodegradation of single-walled carbon nanotubes by eosinophil peroxidase. Small May 27 2013, (Epub ahead of print).
113. Zhou H., Mu Q., Gao N., Liu A., Xing Y., Gao S., Zhang Q., Qu G., Chen Y., Liu G., Zhang B., Yan B. A nano-combinatorial library strategy for the discovery of nanotubes with reduced protein-binding, cytotoxicity, and immune response. Nano Lett. 2008, 8:859-865.
114. Li R., Wang X., Ji Z., Sun B., Zhang H., Chang C.H., Lin S., Meng H., Liao Y.P., Wang M., Li Z., Hwang A.A., Song T.B., Xu R., Yang Y., Zink J.I., Nel A.E., Xia T. Surface charge and cellular processing of covalently functionalized multiwall carbon nanotubes determine pulmonary toxicity. ACS Nano 2013, 7:2352-2368.
115. Pietroiusti A., Campagnolo L., Fadeel B. Interactions of engineered nanoparticles with organs protected by internal biological barriers. Small 2013, 9:1557-1572.